{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:22:09Z","timestamp":1791206529304,"version":"4.1.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bone is a common secondary site of dissemination during the course of cancer. Bone metastases (BM) can be associated with skeletal-related events (SRE) such as disabling pain, hypercalcemia, and bone instability that leads to pathological fractures or spinal cord compression. SRE contribute to high morbidity as well as, mortality, and have a negative economic impact. Modern management of BM integrates focal treatments (such as radiotherapy, surgery, and interventional radiology), orthoses, and antiresorptive and systemic oncological treatment. The choice of a metastasis-directed therapy depends on the objective of the treatment, the patient characteristics, and the complete assessment of the bone lesion (pain, neurological risk, and instability). In the narrative review present herein, we aim to provide an updated summary of the literature, with description of the advantages and disadvantages of current and emerging strategies in the multimodal treatment of BM and, based on these data, an updated algorithm for the management of BM.<\/jats:p>","DOI":"10.1007\/s10555-025-10262-6","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:05:01Z","timestamp":1744477501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["State-of-the-art\u00a0of multidisciplinary approach of bone metastasis-directed therapy: review and challenging questions for preparation of a GEMO practice guidelines"],"prefix":"10.1007","volume":"44","author":[{"given":"Emmanuel","family":"Mesny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Martz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Stacoffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Claren\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nacer","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Sirveaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Thureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"10262_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115783","volume":"158","author":"C Ryan","year":"2022","unstructured":"Ryan, C., Stoltzfus, K. C., Horn, S., Chen, H., Louie, A. V., Lehrer, E. J., et al. (2022). Epidemiology of bone metastases. Bone, 158, 115783. https:\/\/doi.org\/10.1016\/j.bone.2020.115783","journal-title":"Bone"},{"key":"10262_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2022.100446","volume":"35","author":"R Van den Brande","year":"2022","unstructured":"Van den Brande, R., Cornips, E. M., Peeters, M., Ost, P., Billiet, C., & Van de Kelft, E. (2022). Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review. Journal Bone Oncology, 35, 100446. https:\/\/doi.org\/10.1016\/j.jbo.2022.100446","journal-title":"Journal Bone Oncology"},{"key":"10262_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/JTO.0b013e318206a1e3","volume":"6","author":"C Decroisette","year":"2011","unstructured":"Decroisette, C., Monnet, I., Berard, H., Quere, G., Le Caer, H., Bota, S., et al. (2011). Epidemiology and treatment costs of bone metastases from lung cancer: A French prospective, observational, multicenter study (GFPC 0601). Journal Thoracic Oncology Office Publication International Association Study Lung Cancer, 6, 576\u2013582. https:\/\/doi.org\/10.1097\/JTO.0b013e318206a1e3","journal-title":"Journal Thoracic Oncology Office Publication International Association Study Lung Cancer"},{"key":"10262_CR4","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1200\/JCO.2017.72.7362","volume":"35","author":"O Barzilai","year":"2017","unstructured":"Barzilai, O., Laufer, I., Yamada, Y., Higginson, D. S., Schmitt, A. M., Lis, E., et al. (2017). Integrating evidence-based medicine for treatment of spinal metastases into a decision framework: Neurologic, oncologic, mechanicals stability, and systemic disease. Journal Clinical Oncology Office Journal American Society Clinical Oncology, 35, 2419\u20132427. https:\/\/doi.org\/10.1200\/JCO.2017.72.7362","journal-title":"Journal Clinical Oncology Office Journal American Society Clinical Oncology"},{"issue":"23","key":"10262_CR5","doi-asserted-by":"publisher","first-page":"00093","DOI":"10.1053\/j.semnuclmed.2023.11.005","volume":"S0001\u20132998","author":"N Zamani-Siahkali","year":"2024","unstructured":"Zamani-Siahkali, N., Mirshahvalad, S. A., Farbod, A., Divband, G., Pirich, C., Veit-Haibach, P., et al. (2024). SPECT\/CT, PET\/CT, and PET\/MRI for response assessment of bone metastases. Seminars in Nuclear Medicine, S0001\u20132998(23), 00093\u201300094. https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.11.005","journal-title":"Seminars in Nuclear Medicine"},{"key":"10262_CR6","first-page":"256","volume":"249","author":"H Mirels","year":"1989","unstructured":"Mirels, H. (1989). Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clinical Orthopaedica, 249, 256\u201364.","journal-title":"Clinical Orthopaedica"},{"key":"10262_CR7","first-page":"566","volume":"86","author":"YM Van der Linden","year":"2004","unstructured":"Van der Linden, Y. M., Dijkstra, P. D. S., Kroon, H. M., Lok, J. J., Noordijk, E. M., Leer, J. W. H., et al. (2004). Comparative analysis of risk factors for pathological fracture with femoral metastases. Journal of Bone and Joint Surgery. British Volume, 86, 566\u2013573.","journal-title":"Journal of Bone and Joint Surgery. British Volume"},{"key":"10262_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","volume":"13","author":"MH Bilsky","year":"2010","unstructured":"Bilsky, M. H., Laufer, I., Fourney, D. R., Groff, M., Schmidt, M. H., Varga, P. P., et al. (2010). Reliability analysis of the epidural spinal cord compression scale. Journal of Neurosurgery. Spine, 13, 324\u2013328. https:\/\/doi.org\/10.3171\/2010.3.SPINE09459","journal-title":"Journal of Neurosurgery. Spine"},{"key":"10262_CR9","doi-asserted-by":"publisher","unstructured":"KD Harrington 1997 Orthopedic surgical management of skeletal complications of malignancy Cancer 80 1614 1627 https:\/\/doi.org\/10.1002\/(sici)1097-0142(19971015)80:8+<1614::aid-cncr12>3.3.co;2-0","DOI":"10.1002\/(sici)1097-0142(19971015)80:8+<1614::aid-cncr12>3.3.co;2-0"},{"key":"10262_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s007010050199","volume":"140","author":"J Klekamp","year":"1998","unstructured":"Klekamp, J., & Samii, H. (1998). Surgical results for spinal metastases. Acta Neurochirurgica. Supplementum, 140, 957\u2013967. https:\/\/doi.org\/10.1007\/s007010050199","journal-title":"Acta Neurochirurgica. Supplementum"},{"key":"10262_CR11","doi-asserted-by":"publisher","first-page":"i25","DOI":"10.1093\/nop\/npaa056","volume":"7","author":"WC Newman","year":"2020","unstructured":"Newman, W. C., Patel, A., Goldberg, J. L., & Bilsky, M. H. (2020). The importance of multidisciplinary care for spine metastases: Initial tumor management. Neuro-Oncology Practice, 7, i25-32. https:\/\/doi.org\/10.1093\/nop\/npaa056","journal-title":"Neuro-Oncology Practice"},{"key":"10262_CR12","unstructured":"Health Quality Ontario 2016Vertebral Augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: A systematic reviewOnt Health Technology Assessment Series 16 1 202"},{"key":"10262_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.diii.2019.07.005","volume":"100","author":"J Garnon","year":"2019","unstructured":"Garnon, J., Meylheuc, L., Cazzato, R. L., Dalili, D., Koch, G., Auloge, P., et al. (2019). Percutaneous extra-spinal cementoplasty in patients with cancer: A systematic review of procedural details and clinical outcomes. Diagnostic and Interventional Imaging, 100, 743\u2013752. https:\/\/doi.org\/10.1016\/j.diii.2019.07.005","journal-title":"Diagnostic and Interventional Imaging"},{"key":"10262_CR14","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.jvir.2020.08.002","volume":"31","author":"TI Mehta","year":"2020","unstructured":"Mehta, T. I., Heiberger, C., Kazi, S., Brown, M., Weissman, S., Hong, K., et al. (2020). Effectiveness of radiofrequency ablation in the treatment of painful osseous metastases: A correlation meta-analysis with machine learning cluster identification. Journal Vascular Interventional Radiology JVIR, 31, 1753\u20131762. https:\/\/doi.org\/10.1016\/j.jvir.2020.08.002","journal-title":"Journal Vascular Interventional Radiology JVIR"},{"key":"10262_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s00270-023-03417-x","volume":"46","author":"J Levy","year":"2023","unstructured":"Levy, J., David, E., Hopkins, T., Morris, J., Tran, N. D., Farid, H., et al. (2023). Radiofrequency ablation provides rapid and durable pain relief for the palliative treatment of lytic bone metastases independent of radiation therapy: Final results from the OsteoCool Tumor Ablation Post-Market Study. Cardiovascular and Interventional Radiology, 46, 600\u2013609. https:\/\/doi.org\/10.1007\/s00270-023-03417-x","journal-title":"Cardiovascular and Interventional Radiology"},{"key":"10262_CR16","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/papr.12707","volume":"18","author":"L Ferrer-Mileo","year":"2018","unstructured":"Ferrer-Mileo, L., Luque Blanco, A. I., & Gonz\u00e1lez-Barboteo, J. (2018). Efficacy of cryoablation to control cancer pain: A systematic review. Pain Practice Office Journal World Institute Pain, 18, 1083\u20131098. https:\/\/doi.org\/10.1111\/papr.12707","journal-title":"Pain Practice Office Journal World Institute Pain"},{"key":"10262_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129021","volume":"10","author":"M Di Staso","year":"2015","unstructured":"Di Staso, M., Gravina, G. L., Zugaro, L., Bonfili, P., Gregori, L., Franzese, P., et al. (2015). Treatment of solitary painful osseous metastases with radiotherapy, cryoablation or combined therapy: Propensity matching analysis in 175 patients. PLoS ONE, 10, e0129021. https:\/\/doi.org\/10.1371\/journal.pone.0129021","journal-title":"PLoS ONE"},{"key":"10262_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00590-015-1726-y","volume":"26","author":"G Facchini","year":"2016","unstructured":"Facchini, G., Di Tullio, P., Battaglia, M., Bartalena, T., Tetta, C., Errani, C., et al. (2016). Palliative embolization for metastases of the spine. Europaea Journal Orthopaedica Surgery Traumatologica Orthopaedica Traumatologica, 26, 247\u2013252. https:\/\/doi.org\/10.1007\/s00590-015-1726-y","journal-title":"Europaea Journal Orthopaedica Surgery Traumatologica Orthopaedica Traumatologica"},{"key":"10262_CR19","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jvir.2010.12.023","volume":"22","author":"G Rossi","year":"2011","unstructured":"Rossi, G., Mavrogenis, A. F., Rimondi, E., Braccaioli, L., Calabr\u00f2, T., & Ruggieri, P. (2011). Selective embolization with N-butyl cyanoacrylate for metastatic bone disease. Journal Vascular Interventional Radiology JVIR, 22, 462\u2013470. https:\/\/doi.org\/10.1016\/j.jvir.2010.12.023","journal-title":"Journal Vascular Interventional Radiology JVIR"},{"issue":"186","key":"10262_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejca.2023.03.012","volume":"2023","author":"F Deschamps","year":"1990","unstructured":"Deschamps, F., Tselikas, L., Yevich, S., Bonnet, B., Roux, C., Kobe, A., et al. (1990). Electrochemotherapy in radiotherapy-resistant epidural spinal cord compression in metastatic cancer patients. Europaea Journal Cancer Oxford England, 2023(186), 62\u201368. https:\/\/doi.org\/10.1016\/j.ejca.2023.03.012","journal-title":"Europaea Journal Cancer Oxford England"},{"key":"10262_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.radonc.2018.01.003","volume":"126","author":"SE Rich","year":"2018","unstructured":"Rich, S. E., Chow, R., Raman, S., Liang Zeng, K., Lutz, S., Lam, H., et al. (2018). Update of the systematic review of palliative radiation therapy fractionation for bone metastases. Radiotherapy Oncology Journal Europaea Society Therapy Radiology Oncology, 126, 547\u2013557. https:\/\/doi.org\/10.1016\/j.radonc.2018.01.003","journal-title":"Radiotherapy Oncology Journal Europaea Society Therapy Radiology Oncology"},{"key":"10262_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103775","volume":"178","author":"CC Lee","year":"2022","unstructured":"Lee, C. C., Soon, Y. Y., Cheo, T., Vellayappan, B., & Tey, J. (2022). Stereotactic body radiation therapy versus conventional external beam radiation therapy for painful bone metastases: A systematic review and meta-analysis of randomized trials. Critical Reviews in Oncology Hematology, 178, 103775. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103775","journal-title":"Critical Reviews in Oncology Hematology"},{"key":"10262_CR23","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1016\/S0167-8140(23)08562-6","volume":"182","author":"C Mercier","year":"2023","unstructured":"Mercier, C., Billiet, C., Joye, I., Meijnders, P., Nevens, D., Ost, P., et al. (2023). OC-0267 Long-term results of an SBRT dose-escalation trial for bone and lymph node metastases (NCT03486431). Radiotherapy and Oncology, 182, S203\u2013S204. https:\/\/doi.org\/10.1016\/S0167-8140(23)08562-6","journal-title":"Radiotherapy and Oncology"},{"key":"10262_CR24","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamaoncol.2023.0356","volume":"9","author":"S Ryu","year":"2023","unstructured":"Ryu, S., Deshmukh, S., Timmerman, R. D., Movsas, B., Gerszten, P., Yin, F.-F., et al. (2023). Stereotactic radiosurgery vs conventional radiotherapy for localized vertebral metastases of the spine: Phase 3 results of NRG Oncology\/RTOG 0631 Randomized Clinical Trial. JAMA Oncology, 9, 800\u2013807. https:\/\/doi.org\/10.1001\/jamaoncol.2023.0356","journal-title":"JAMA Oncology"},{"key":"10262_CR25","doi-asserted-by":"publisher","first-page":"109969","DOI":"10.1016\/j.radonc.2023.109969","volume":"190","author":"RS Guninski","year":"2023","unstructured":"Guninski, R. S., Cuccia, F., Alongi, F., Andratschke, N., Belka, C., Bellut, D., et al. (2023). Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline. Radiotherapy Oncology Journal Europaea Society Therapy Radiology Oncology, 190, 109969. https:\/\/doi.org\/10.1016\/j.radonc.2023.109969","journal-title":"Radiotherapy Oncology Journal Europaea Society Therapy Radiology Oncology"},{"key":"10262_CR26","doi-asserted-by":"publisher","first-page":"109966","DOI":"10.1016\/j.radonc.2023.109966","volume":"190","author":"M Guckenberger","year":"2023","unstructured":"Guckenberger, M., Andratschke, N., Belka, C., Bellut, D., Cuccia, F., Dahele, M., et al. (2023). ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases. Radiotherapy Oncology Journal Europaea Society Therapy Radiology Oncology, 190, 109966. https:\/\/doi.org\/10.1016\/j.radonc.2023.109966","journal-title":"Radiotherapy Oncology Journal Europaea Society Therapy Radiology Oncology"},{"issue":"24","key":"10262_CR27","doi-asserted-by":"publisher","first-page":"00099","DOI":"10.1016\/j.prro.2024.04.018","volume":"S1879\u20138500","author":"S Alcorn","year":"2024","unstructured":"Alcorn, S., Cort\u00e9s, \u00c1. A., Bradfield, L., Brennan, M., Dennis, K., Diaz, D. A., et al. (2024). External beam radiation therapy for palliation of symptomatic bone metastases: An ASTRO Clinical Practice Guideline. Practical Radiation Oncology, S1879\u20138500(24), 00099\u201300107. https:\/\/doi.org\/10.1016\/j.prro.2024.04.018","journal-title":"Practical Radiation Oncology"},{"key":"10262_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","volume":"128","author":"T Sprave","year":"2018","unstructured":"Sprave, T., Verma, V., F\u00f6rster, R., Schlampp, I., Bruckner, T., Bostel, T., et al. (2018). Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. Radiotherapy and Oncology, 128, 274\u2013282. https:\/\/doi.org\/10.1016\/j.radonc.2018.04.030","journal-title":"Radiotherapy and Oncology"},{"key":"10262_CR29","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jamaoncol.2019.0192","volume":"5","author":"Q-N Nguyen","year":"2019","unstructured":"Nguyen, Q.-N., Chun, S. G., Chow, E., Komaki, R., Liao, Z., Zacharia, R., et al. (2019). Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: A randomized phase 2 trial. JAMA Oncology, 5, 872\u2013878. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0192","journal-title":"JAMA Oncology"},{"key":"10262_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijrobp.2020.11.060","volume":"110","author":"BJ Pielkenrood","year":"2021","unstructured":"Pielkenrood, B. J., van der Velden, J. M., van der Linden, Y. M., Bartels, M. M. T., Kasperts, N., Verhoeff, J. J. C., et al. (2021). Pain response after stereotactic body radiation therapy versus conventional radiation therapy in patients with bone metastases\u2014A phase 2 randomized controlled trial within a prospective cohort. International Journal Radiation Oncology, 110, 358\u2013367. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.11.060","journal-title":"International Journal Radiation Oncology"},{"key":"10262_CR31","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","volume":"22","author":"A Sahgal","year":"2021","unstructured":"Sahgal, A., Myrehaug, S. D., Siva, S., Masucci, G. L., Maralani, P. J., Brundage, M., et al. (2021). Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: An open-label, multicentre, randomised, controlled, phase 2\/3 trial. The lancet Oncology, 22, 1023\u20131033. https:\/\/doi.org\/10.1016\/S1470-2045(21)00196-0","journal-title":"The lancet Oncology"},{"key":"10262_CR32","doi-asserted-by":"crossref","unstructured":"Mercier, C.(2023). Single fraction SBRT vs 3D-CRT for painful bone metastases: A singleblind phase 3 RCT (NCT03831243). ESTRO Annu Meet 2023.","DOI":"10.1016\/S0167-8140(23)08703-0"},{"key":"10262_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1200\/JCO.23.00753","volume":"42","author":"EF Gillespie","year":"2024","unstructured":"Gillespie, E. F., Yang, J. C., Mathis, N. J., Marine, C. B., White, C., Zhang, Z., et al. (2024). Prophylactic radiation therapy versus standard of care for patients with high-risk asymptomatic bone metastases: A multicenter, randomized phase II clinical trial. Journal of Clinical Oncology, 42, 38\u201346. https:\/\/doi.org\/10.1200\/JCO.23.00753","journal-title":"Journal of Clinical Oncology"},{"key":"10262_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/0269215516648753","volume":"31","author":"M Nadler","year":"2017","unstructured":"Nadler, M., & Pauls, M. (2017). Shoulder orthoses for the prevention and reduction of hemiplegic shoulder pain and subluxation: Systematic review. Clinical Rehabilitation, 31, 444\u2013453. https:\/\/doi.org\/10.1177\/0269215516648753","journal-title":"Clinical Rehabilitation"},{"key":"10262_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1471-2474-11-145","volume":"11","author":"A Fottner","year":"2010","unstructured":"Fottner, A., Szalantzy, M., Wirthmann, L., St\u00e4hler, M., Baur-Melnyk, A., Jansson, V., et al. (2010). Bone metastases from renal cell carcinoma: Patient survival after surgical treatment. BMC Musculoskeletal Disorders, 11, 145. https:\/\/doi.org\/10.1186\/1471-2474-11-145","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10262_CR36","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.2106\/JBJS.F.00603","volume":"89","author":"PP Lin","year":"2007","unstructured":"Lin, P. P., Mirza, A. N., Lewis, V. O., Cannon, C. P., Tu, S.-M., Tannir, N. M., et al. (2007). Patient survival after surgery for osseous metastases from renal cell carcinoma. Journal of Bone and Joint Surgery. American Volume, 89, 1794\u20131801. https:\/\/doi.org\/10.2106\/JBJS.F.00603","journal-title":"Journal of Bone and Joint Surgery. American Volume"},{"key":"10262_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00003086-200203000-00029","volume":"396","author":"HR D\u00fcrr","year":"2002","unstructured":"D\u00fcrr, H. R., M\u00fcller, P. E., Lenz, T., Baur, A., Jansson, V., & Refior, H. J. (2002). Surgical treatment of bone metastases in patients with breast cancer. Clinical Orthopaedics, 396, 191\u20136.","journal-title":"Clinical Orthopaedics"},{"key":"10262_CR38","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.3390\/jcm11123265","volume":"11","author":"F Sgalambro","year":"2022","unstructured":"Sgalambro, F., Zugaro, L., Bruno, F., Palumbo, P., Salducca, N., Zoccali, C., et al. (2022). Interventional radiology in the management of metastases and bone tumors. Journal of Clinical Medicine, 11, 3265. https:\/\/doi.org\/10.3390\/jcm11123265","journal-title":"Journal of Clinical Medicine"},{"key":"10262_CR39","doi-asserted-by":"publisher","unstructured":"Moraes, F.Y, Gouveia, A.G, Marta, G.N, da Silva, M.F, Hamamura, A.C, Tsakiridis T, et al. (2024) Meta-Analysis of STereotactic body radiothERapy in non-spine BONE metastaseS (MASTER-BONES). International Journal Radiation Oncology Bioliogy Physics 0. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.12.045.","DOI":"10.1016\/j.ijrobp.2023.12.045"},{"issue":"24","key":"10262_CR40","doi-asserted-by":"publisher","first-page":"00024","DOI":"10.1016\/j.ijrobp.2023.12.051","volume":"S0360\u20133016","author":"R Singh","year":"2024","unstructured":"Singh, R., Valluri, A., Lehrer, E. J., Cao, Y., Upadhyay, R., Trifiletti, D. M., et al. (2024). Clinical outcomes following stereotactic body radiation therapy (SBRT) for non-spinal bone metastases: A systematic review and meta-analysis. International Journal of Radiation Oncology Biology Physics, S0360\u20133016(24), 00024\u201300025. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.12.051","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"10262_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/ijc.32509","volume":"146","author":"P Bowden","year":"2020","unstructured":"Bowden, P., See, A. W., Frydenberg, M., Haxhimolla, H., Costello, A. J., Moon, D., et al. (2020). Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial. International Journal of Cancer, 146, 161\u2013168. https:\/\/doi.org\/10.1002\/ijc.32509","journal-title":"International Journal of Cancer"},{"key":"10262_CR42","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jamaoncol.2023.0161","volume":"9","author":"C Tang","year":"2023","unstructured":"Tang, C., Sherry, A. D., Haymaker, C., Bathala, T., Liu, S., Fellman, B., et al. (2023). Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer: The EXTEND phase 2 randomized clinical trial. JAMA Oncology, 9, 825\u2013834. https:\/\/doi.org\/10.1001\/jamaoncol.2023.0161","journal-title":"JAMA Oncology"},{"key":"10262_CR43","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","volume":"6","author":"R Phillips","year":"2020","unstructured":"Phillips, R., Shi, W. Y., Deek, M., Radwan, N., Lim, S. J., Antonarakis, E. S., et al. (2020). Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: The ORIOLE phase 2 randomized clinical trial. JAMA Oncology, 6, 650\u2013659. https:\/\/doi.org\/10.1001\/jamaoncol.2020.0147","journal-title":"JAMA Oncology"},{"key":"10262_CR44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.eururo.2018.06.004","volume":"74","author":"S Siva","year":"2018","unstructured":"Siva, S., Bressel, M., Murphy, D. G., Shaw, M., Chander, S., Violet, J., et al. (2018). Stereotactic Abative Body Radiotherapy (SABR) for oligometastatic prostate cancer: A prospective clinical trial. European Urology, 74, 455\u2013462. https:\/\/doi.org\/10.1016\/j.eururo.2018.06.004","journal-title":"European Urology"},{"key":"10262_CR45","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201s","volume":"37","author":"DR Gomez","year":"2019","unstructured":"Gomez, D. R., Tang, C., Zhang, J., Blumenschein, G. R., Hernandez, M., Lee, J. J., et al. (2019). Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study. Journal Clinical Oncology Office Journal American Society Clinical Oncology, 37, 1558\u201365. https:\/\/doi.org\/10.1200\/JCO.19.00201s","journal-title":"Journal Clinical Oncology Office Journal American Society Clinical Oncology"},{"key":"10262_CR46","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3501","volume":"4","author":"P Iyengar","year":"2018","unstructured":"Iyengar, P., Wardak, Z., Gerber, D. E., Tumati, V., Ahn, C., Hughes, R. S., et al. (2018). Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: A phase 2 randomized clinical trial. JAMA Oncology, 4, e173501. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3501","journal-title":"JAMA Oncology"},{"key":"10262_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0140-6736(23)01857-3","volume":"403","author":"CJ Tsai","year":"2024","unstructured":"Tsai, C. J., Yang, J. T., Shaverdian, N., Patel, J., Shepherd, A. F., Eng, J., et al. (2024). Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study. Lancet London England, 403, 171\u2013182. https:\/\/doi.org\/10.1016\/S0140-6736(23)01857-3","journal-title":"Lancet London England"},{"key":"10262_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2023.100496","volume":"42","author":"J Lee","year":"2023","unstructured":"Lee, J., Kim, J. A., An, T. J., Lee, H., Han, E. J., Sa, Y. J., et al. (2023). Optimal timing for local ablative treatment of bone oligometastases in non-small cell lung cancer. Journal Bone Oncology, 42, 100496. https:\/\/doi.org\/10.1016\/j.jbo.2023.100496","journal-title":"Journal Bone Oncology"},{"key":"10262_CR49","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., et al. (2010). Early palliative care for patients with metastatic non-small-cell lung cancer. New England Journal of Medicine, 363, 733\u2013742. https:\/\/doi.org\/10.1056\/NEJMoa1000678","journal-title":"New England Journal of Medicine"},{"key":"10262_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","volume":"148","author":"Y Lievens","year":"2020","unstructured":"Lievens, Y., Guckenberger, M., Gomez, D., Hoyer, M., Iyengar, P., Kindts, I., et al. (2020). Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document. Radiotherapy Oncology Journal Europaea Society Therapy Radiology Oncology, 148, 157\u2013166. https:\/\/doi.org\/10.1016\/j.radonc.2020.04.003","journal-title":"Radiotherapy Oncology Journal Europaea Society Therapy Radiology Oncology"},{"key":"10262_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.radonc.2021.02.011","volume":"158","author":"NG Zaorsky","year":"2021","unstructured":"Zaorsky, N. G., Liang, M., Patel, R., Lin, C., Tchelebi, L. T., Newport, K. B., et al. (2021). Survival after palliative radiation therapy for cancer: The METSSS model. Radiotherapy Oncology Journal Europaea Society Therapy Radiology Oncology, 158, 104\u2013111. https:\/\/doi.org\/10.1016\/j.radonc.2021.02.011","journal-title":"Radiotherapy Oncology Journal Europaea Society Therapy Radiology Oncology"},{"key":"10262_CR52","doi-asserted-by":"publisher","first-page":"1349586","DOI":"10.3389\/fsurg.2024.1349586","volume":"11","author":"D Mavritsakis","year":"2024","unstructured":"Mavritsakis, D., & Amiot, L.-P. (2024). A novel prognostic scoring system combining the revised Tokuhashi score and the New England spinal metastasis score for preoperative evaluation of spinal metastases. Frontiers Surgery, 11, 1349586. https:\/\/doi.org\/10.3389\/fsurg.2024.1349586","journal-title":"Frontiers Surgery"},{"key":"10262_CR53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/BF00180229","volume":"18","author":"K Tomita","year":"1994","unstructured":"Tomita, K., Kawahara, N., Baba, H., Tsuchiya, H., Nagata, S., & Toribatake, Y. (1994). Total en bloc spondylectomy for solitary spinal metastases. International Orthopaedics, 18, 291\u2013298. https:\/\/doi.org\/10.1007\/BF00180229","journal-title":"International Orthopaedics"},{"key":"10262_CR54","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","volume":"366","author":"RA Patchell","year":"2005","unstructured":"Patchell, R. A., Tibbs, P. A., Regine, W. F., Payne, R., Saris, S., Kryscio, R. J., et al. (2005). Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: A randomised trial. Lancet London England, 366, 643\u2013648. https:\/\/doi.org\/10.1016\/S0140-6736(05)66954-1","journal-title":"Lancet London England"},{"key":"10262_CR55","doi-asserted-by":"publisher","unstructured":"Schupper, A. J, Patel, S, Steinberger, J. M, Germano, I. M. (2023). The role of minimally invasive surgery within a multidisciplinary approach for patients with metastatic spine disease over a decade: A systematic review. Neuro-Oncology noad206. https:\/\/doi.org\/10.1093\/neuonc\/noad206.","DOI":"10.1093\/neuonc\/noad206"},{"key":"10262_CR56","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.prro.2021.10.004","volume":"12","author":"S Faruqi","year":"2022","unstructured":"Faruqi, S., Chen, H., Fariselli, L., Levivier, M., Ma, L., Paddick, I., et al. (2022). Stereotactic radiosurgery for postoperative spine malignancy: A systematic review and international stereotactic radiosurgery society practice guidelines. Practical Radiation Oncology, 12, e65-78. https:\/\/doi.org\/10.1016\/j.prro.2021.10.004","journal-title":"Practical Radiation Oncology"},{"key":"10262_CR57","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3171\/2016.8.SPINE16121","volume":"26","author":"KJ Redmond","year":"2017","unstructured":"Redmond, K. J., Lo, S. S., Soltys, S. G., Yamada, Y., Barani, I. J., Brown, P. D., et al. (2017). Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: Results of an international survey. Journal of Neurosurgery. Spine, 26, 299\u2013306. https:\/\/doi.org\/10.3171\/2016.8.SPINE16121","journal-title":"Journal of Neurosurgery. Spine"},{"key":"10262_CR58","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.arth.2014.12.017","volume":"30","author":"JA Karam","year":"2015","unstructured":"Karam, J. A., Huang, R. C., Abraham, J. A., & Parvizi, J. (2015). Total joint arthroplasty in cancer patients. Journal of Arthroplasty, 30, 758\u2013761. https:\/\/doi.org\/10.1016\/j.arth.2014.12.017","journal-title":"Journal of Arthroplasty"},{"key":"10262_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/00016470410001708270","volume":"75","author":"BH Hansen","year":"2004","unstructured":"Hansen, B. H., Keller, J., Laitinen, M., Berg, P., Skjeldal, S., Trovik, C., et al. (2004). The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities. Acta Orthopaedica Scandinavica Supplementum, 75, 11\u20135. https:\/\/doi.org\/10.1080\/00016470410001708270","journal-title":"Acta Orthopaedica Scandinavica Supplementum"},{"key":"10262_CR60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jbspin.2018.03.005","volume":"86","author":"CB Confavreux","year":"2019","unstructured":"Confavreux, C. B., Pialat, J.-B., Belli\u00e8re, A., Brevet, M., Decroisette, C., Tescaru, A., et al. (2019). Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology management. Joint, Bone, Spine, 86, 185\u2013194. https:\/\/doi.org\/10.1016\/j.jbspin.2018.03.005","journal-title":"Joint, Bone, Spine"},{"key":"10262_CR61","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1016\/j.arth.2020.06.080","volume":"35","author":"M Sloan","year":"2020","unstructured":"Sloan, M., & Lee, G.-C. (2020). Mortality and complications in patients with metastatic disease after primary total hip and total knee arthroplasty. Journal of Arthroplasty, 35, 3512\u20133516. https:\/\/doi.org\/10.1016\/j.arth.2020.06.080","journal-title":"Journal of Arthroplasty"},{"key":"10262_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4087","volume":"371","author":"TP Hanna","year":"2020","unstructured":"Hanna, T. P., King, W. D., Thibodeau, S., Jalink, M., Paulin, G. A., Harvey-Jones, E., et al. (2020). Mortality due to cancer treatment delay: Systematic review and meta-analysis. BMJ, 371, m4087. https:\/\/doi.org\/10.1136\/bmj.m4087","journal-title":"BMJ"},{"key":"10262_CR63","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1016\/S1470-2045(22)00752-5","volume":"24","author":"SGC Kroeze","year":"2023","unstructured":"Kroeze, S. G. C., Pavic, M., Stellamans, K., Lievens, Y., Becherini, C., Scorsetti, M., et al. (2023). Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: Systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium. The lancet Oncology, 24, e121\u2013e132. https:\/\/doi.org\/10.1016\/S1470-2045(22)00752-5","journal-title":"The lancet Oncology"},{"key":"10262_CR64","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1097\/BRS.0b013e3182a46576","volume":"38","author":"S Kato","year":"2013","unstructured":"Kato, S., Hozumi, T., Takaki, Y., Yamakawa, K., Goto, T., & Kondo, T. (2013). Optimal schedule of preoperative embolization for spinal metastasis surgery. Spine, 38, 1964\u20131969. https:\/\/doi.org\/10.1097\/BRS.0b013e3182a46576","journal-title":"Spine"},{"key":"10262_CR65","doi-asserted-by":"publisher","first-page":"740","DOI":"10.5152\/dir.2021.21011","volume":"27","author":"EC \u00c7elebio\u011flu","year":"2021","unstructured":"\u00c7elebio\u011flu, E. C., Bilgi\u00e7, S., Merter, A., Karaca, M. O., Ba\u015far\u0131r, K., & Y\u0131ld\u0131z, H. Y. (2021). Scheduling surgery after transarterial embolization: Does timing make any difference to intraoperative blood loss for renal cell carcinoma bone metastases? Diagnostic Interventional Radiology Ankara Turkey, 27, 740\u2013745. https:\/\/doi.org\/10.5152\/dir.2021.21011","journal-title":"Diagnostic Interventional Radiology Ankara Turkey"},{"key":"10262_CR66","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-0037-1608747","volume":"34","author":"A Kelekis","year":"2017","unstructured":"Kelekis, A., Cornelis, F. H., Tutton, S., & Filippiadis, D. (2017). Metastatic osseous pain control: Bone ablation and cementoplasty. Seminars in Interventional Radiology, 34, 328\u2013336. https:\/\/doi.org\/10.1055\/s-0037-1608747","journal-title":"Seminars in Interventional Radiology"},{"key":"10262_CR67","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/jbm.820180411","volume":"18","author":"S Saha","year":"1984","unstructured":"Saha, S., & Pal, S. (1984). Mechanical properties of bone cement: A review. Journal of Biomedical Materials Research, 18, 435\u2013462. https:\/\/doi.org\/10.1002\/jbm.820180411","journal-title":"Journal of Biomedical Materials Research"},{"key":"10262_CR68","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jbspin.2017.05.005","volume":"85","author":"J-D Laredo","year":"2018","unstructured":"Laredo, J.-D., Chiras, J., Kemel, S., Taihi, L., & Hamze, B. (2018). Vertebroplasty and interventional radiology procedures for bone metastases. Joint, Bone, Spine, 85, 191\u2013199. https:\/\/doi.org\/10.1016\/j.jbspin.2017.05.005","journal-title":"Joint, Bone, Spine"},{"key":"10262_CR69","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221401","volume":"307","author":"CM Dussik","year":"2023","unstructured":"Dussik, C. M., Toombs, C., Alder, K. D., Yu, K. E., Berson, E. R., Ibe, I. K., et al. (2023). Percutaneous ablation, osteoplasty, reinforcement, and internal fixation for pain and ambulatory function in periacetabular osteolytic malignancies. Radiology, 307, e221401. https:\/\/doi.org\/10.1148\/radiol.221401","journal-title":"Radiology"},{"key":"10262_CR70","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00270-022-03186-z","volume":"45","author":"S Bertholon","year":"2022","unstructured":"Bertholon, S., Grange, R., Thomas, T., Tetard, M.-C., Barral, F.-G., Beneton, A., et al. (2022). Combination of percutaneous screw fixation and cementoplasty for lytic bone metastases: Feasibility, safety and clinical outcomes. Cardiovascular and Interventional Radiology, 45, 1129\u20131133. https:\/\/doi.org\/10.1007\/s00270-022-03186-z","journal-title":"Cardiovascular and Interventional Radiology"},{"key":"10262_CR71","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1007\/s00270-011-0330-8","volume":"35","author":"F Deschamps","year":"2012","unstructured":"Deschamps, F., Farouil, G., Hakime, A., Teriitehau, C., Barah, A., & de Baere, T. (2012). Percutaneous stabilization of impending pathological fracture of the proximal femur. Cardiovascular and Interventional Radiology, 35, 1428\u20131432. https:\/\/doi.org\/10.1007\/s00270-011-0330-8","journal-title":"Cardiovascular and Interventional Radiology"},{"key":"10262_CR72","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s00330-019-06525-w","volume":"30","author":"F Claren\u00e7on","year":"2020","unstructured":"Claren\u00e7on, F., Fahed, R., Cormier, E., Haffaf, I., Spano, J.-P., Shotar, E., et al. (2020). Safety and effectiveness of cervical vertebroplasty: Report of a large cohort and systematic review. European Radiology, 30, 1571\u20131583. https:\/\/doi.org\/10.1007\/s00330-019-06525-w","journal-title":"European Radiology"},{"key":"10262_CR73","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1055\/s-0042-1745787","volume":"39","author":"A Tomasian","year":"2022","unstructured":"Tomasian, A., & Jennings, J. W. (2022). Interventional palliation of painful extraspinal musculoskeletal metastases. Seminars in Interventional Radiology, 39, 176\u2013183. https:\/\/doi.org\/10.1055\/s-0042-1745787","journal-title":"Seminars in Interventional Radiology"},{"key":"10262_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-023-02458-z","author":"T Matsumoto","year":"2024","unstructured":"Matsumoto, T., Yoshimatsu, R., Osaki, M., Shibata, J., Maeda, H., Miyatake, K., et al. (2024). Analgesic efficacy and safety of percutaneous thermal ablation plus cementoplasty for painful bone metastases: A systematic review and meta-analysis. International Journal of Clinical Oncology. https:\/\/doi.org\/10.1007\/s10147-023-02458-z","journal-title":"International Journal of Clinical Oncology"},{"key":"10262_CR75","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12032-016-0848-3","volume":"33","author":"RL Cazzato","year":"2016","unstructured":"Cazzato, R. L., Garnon, J., Ramamurthy, N., Koch, G., Tsoumakidou, G., Caudrelier, J., et al. (2016). Percutaneous image-guided cryoablation: Current applications and results in the oncologic field. Medical Oncology Northwood London England, 33, 140. https:\/\/doi.org\/10.1007\/s12032-016-0848-3","journal-title":"Medical Oncology Northwood London England"},{"key":"10262_CR76","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/cncr.27793","volume":"119","author":"MR Callstrom","year":"2013","unstructured":"Callstrom, M. R., Dupuy, D. E., Solomon, S. B., Beres, R. A., Littrup, P. J., Davis, K. W., et al. (2013). Percutaneous image-guided cryoablation of painful metastases involving bone: Multicenter trial. Cancer, 119, 1033\u20131041. https:\/\/doi.org\/10.1002\/cncr.27793","journal-title":"Cancer"},{"key":"10262_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2022.106819","volume":"286","author":"I Tsoneva","year":"2022","unstructured":"Tsoneva, I., Semkova, S., Bakalova, R., Zhelev, Z., Nuss, P., Staneva, G., et al. (2022). Electroporation, electrochemotherapy and electro-assisted drug delivery in cancer. A state-of-the-art review. Biophysics Chemical, 286, 106819. https:\/\/doi.org\/10.1016\/j.bpc.2022.106819","journal-title":"A state-of-the-art review. Biophysics Chemical"},{"key":"10262_CR78","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1016\/j.ejso.2021.05.004","volume":"47","author":"L Campanacci","year":"2021","unstructured":"Campanacci, L., Bianchi, G., Cevolani, L., Errani, C., Ciani, G., Facchini, G., et al. (2021). Operating procedures for electrochemotherapy in bone metastases: Results from a multicenter prospective study on 102 patients. European Journal Surgery Oncology Journal European Society Surgery Oncology Br Association Surgery Oncology, 47, 2609\u20132617. https:\/\/doi.org\/10.1016\/j.ejso.2021.05.004","journal-title":"European Journal Surgery Oncology Journal European Society Surgery Oncology Br Association Surgery Oncology"},{"key":"10262_CR79","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.radonc.2016.07.009","volume":"121","author":"JJ Willeumier","year":"2016","unstructured":"Willeumier, J. J., van der Linden, Y. M., & Dijkstra, P. D. S. (2016). Lack of clinical evidence for postoperative radiotherapy after surgical fixation of impending or actual pathologic fractures in the long bones in patients with cancer; a systematic review. Radiotherapy Oncology Journal European Society Therapy Radiology Oncology, 121, 138\u2013142. https:\/\/doi.org\/10.1016\/j.radonc.2016.07.009","journal-title":"Radiotherapy Oncology Journal European Society Therapy Radiology Oncology"},{"key":"10262_CR80","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7150\/jca.13377","volume":"7","author":"MJ Wolanczyk","year":"2016","unstructured":"Wolanczyk, M. J., Fakhrian, K., & Adamietz, I. A. (2016). Radiotherapy, bisphosphonates and surgical stabilization of complete or impending pathologic fractures in patients with metastatic bone disease. Journal of Cancer, 7, 121\u2013124. https:\/\/doi.org\/10.7150\/jca.13377","journal-title":"Journal of Cancer"},{"key":"10262_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100756","volume":"6","author":"DB Rosen","year":"2021","unstructured":"Rosen, D. B., Haseltine, J. M., Bartelstein, M., Flynn, J. R., Zhang, Z., Kohutek, Z. A., et al. (2021). Should postoperative radiation for long bone metastases cover part or all of the orthopedic hardware? Results of a large retrospective analysis. Advances in Radiation Oncology, 6, 100756. https:\/\/doi.org\/10.1016\/j.adro.2021.100756","journal-title":"Advances in Radiation Oncology"},{"key":"10262_CR82","doi-asserted-by":"publisher","unstructured":"Piras, A., La Vecchia, M., Boldrini, L., D\u2019Aviero, A., Galanti, D., Guarini, A. et al. (2021). Radiofrequency thermoablation (RFA) and radiotherapy (RT) combined treatment for bone metastases: a systematic review. European Reviews Medicine Pharmacology Science 25 3647\u201354. https:\/\/doi.org\/10.26355\/eurrev_202105_25930.","DOI":"10.26355\/eurrev_202105_25930"},{"key":"10262_CR83","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ijrobp.2012.05.007","volume":"85","author":"A Sahgal","year":"2013","unstructured":"Sahgal, A., Weinberg, V., Ma, L., Chang, E., Chao, S., Muacevic, A., et al. (2013). Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. International Journal of Radiation Oncology Biology Physics, 85, 341\u2013347. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.05.007","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"10262_CR84","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijrobp.2019.09.038","volume":"110","author":"A Sahgal","year":"2021","unstructured":"Sahgal, A., Chang, J. H., Ma, L., Marks, L. B., Milano, M. T., Medin, P., et al. (2021). Spinal cord dose tolerance to stereotactic body radiation therapy. International Journal of Radiation Oncology Biology Physics, 110, 124\u2013136. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.09.038","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"10262_CR85","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","volume":"31","author":"A Sahgal","year":"2013","unstructured":"Sahgal, A., Atenafu, E. G., Chao, S., Al-Omair, A., Boehling, N., Balagamwala, E. H., et al. (2013). Vertebral compression fracture after spine stereotactic body radiotherapy: A multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. Journal Clinical Oncology Office Journal American Society Clinical Oncology, 31, 3426\u20133431. https:\/\/doi.org\/10.1200\/JCO.2013.50.1411","journal-title":"Journal Clinical Oncology Office Journal American Society Clinical Oncology"},{"key":"10262_CR86","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.semradonc.2022.11.006","volume":"33","author":"M Guckenberger","year":"2023","unstructured":"Guckenberger, M., Dahele, M., Ong, W. L., & Sahgal, A. (2023). Stereotactic body radiation therapy for spinal metastases: Benefits and limitations. Seminars in Radiation Oncology, 33, 159\u2013171. https:\/\/doi.org\/10.1016\/j.semradonc.2022.11.006","journal-title":"Seminars in Radiation Oncology"},{"key":"10262_CR87","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ijrobp.2014.07.037","volume":"90","author":"HY Pan","year":"2014","unstructured":"Pan, H. Y., Allen, P. K., Wang, X. S., Chang, E. L., Rhines, L. D., Tatsui, C. E., et al. (2014). Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: Secondary analysis of phase 1\/2 trials. International Journal of Radiation Oncology Biology Physics, 90, 870\u2013876. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.07.037","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"10262_CR88","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","volume":"16","author":"I Thibault","year":"2015","unstructured":"Thibault, I., Chang, E. L., Sheehan, J., Ahluwalia, M. S., Guckenberger, M., Sohn, M.-J., et al. (2015). Response assessment after stereotactic body radiotherapy for spinal metastasis: A report from the SPIne response assessment in Neuro-Oncology (SPINO) group. The Lancet Oncology, 16, e595-603. https:\/\/doi.org\/10.1016\/S1470-2045(15)00166-7","journal-title":"The Lancet Oncology"},{"key":"10262_CR89","doi-asserted-by":"publisher","first-page":"80","DOI":"10.7150\/jca.1.80","volume":"1","author":"CM Costelloe","year":"2010","unstructured":"Costelloe, C. M., Chuang, H. H., & Madewell, J. E. (2010). Ueno NT. Cancer Response Criteria and Bone Metastases: RECIST 1.1 MDA and PERCIST. Journal Cancer, 1, 80\u201392. https:\/\/doi.org\/10.7150\/jca.1.80","journal-title":"Journal Cancer"},{"key":"10262_CR90","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1007\/s00259-017-3703-7","volume":"44","author":"CC Riedl","year":"2017","unstructured":"Riedl, C. C., Pinker, K., Ulaner, G. A., Ong, L. T., Baltzer, P., Jochelson, M. S., et al. (2017). Comparison of FDG-PET\/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer. European Journal of Nuclear Medicine and Molecular Imaging, 44, 1428\u20131437. https:\/\/doi.org\/10.1007\/s00259-017-3703-7","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10262_CR91","doi-asserted-by":"publisher","first-page":"004","DOI":"10.1016\/j.jbo.2018.10.004","volume":"15","author":"S D\u2019Oronzo","year":"2019","unstructured":"D\u2019Oronzo, S., Coleman, R., Brown, J., & Silvestris, F. (2019). Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management. Journal Bone Oncology, 15, 004\u2013004. https:\/\/doi.org\/10.1016\/j.jbo.2018.10.004","journal-title":"Journal Bone Oncology"},{"key":"10262_CR92","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ctrv.2017.10.010","volume":"62","author":"AF de Groot","year":"2018","unstructured":"de Groot, A. F., Appelman-Dijkstra, N. M., van der Burg, S. H., & Kroep, J. R. (2018). The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review. Cancer Treatment Reviews, 62, 18\u201328. https:\/\/doi.org\/10.1016\/j.ctrv.2017.10.010","journal-title":"Cancer Treatment Reviews"},{"key":"10262_CR93","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/jnci\/djh141","volume":"96","author":"F Saad","year":"2004","unstructured":"Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., et al. (2004). Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. Journal of the National Cancer Institute, 96, 879\u2013882. https:\/\/doi.org\/10.1093\/jnci\/djh141","journal-title":"Journal of the National Cancer Institute"},{"key":"10262_CR94","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","volume":"377","author":"K Fizazi","year":"2011","unstructured":"Fizazi, K., Carducci, M., Smith, M., Dami\u00e3o, R., Brown, J., Karsh, L., et al. (2011). Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study. Lancet London England, 377, 813\u2013822. https:\/\/doi.org\/10.1016\/S0140-6736(10)62344-6","journal-title":"Lancet London England"},{"key":"10262_CR95","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","volume":"28","author":"AT Stopeck","year":"2010","unstructured":"Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., et al. (2010). Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: A randomized, double-blind study. Journal Clinical Oncology Office Journal American Society Clinical Oncology, 28, 5132\u20135139. https:\/\/doi.org\/10.1200\/JCO.2010.29.7101","journal-title":"Journal Clinical Oncology Office Journal American Society Clinical Oncology"},{"key":"10262_CR96","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","volume":"19","author":"N Raje","year":"2018","unstructured":"Raje, N., Terpos, E., Willenbacher, W., Shimizu, K., Garc\u00eda-Sanz, R., Durie, B., et al. (2018). Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: An international, double-blind, double-dummy, randomised, controlled, phase 3 study. The Lancet Oncology, 19, 370\u2013381. https:\/\/doi.org\/10.1016\/S1470-2045(18)30072-X","journal-title":"The Lancet Oncology"},{"issue":"53","key":"10262_CR97","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejca.2015.09.011","volume":"2016","author":"A Lipton","year":"1990","unstructured":"Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Smith, M. R., Shore, N., et al. (1990). Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics. European Journal Cancer Oxford England, 2016(53), 75\u201383. https:\/\/doi.org\/10.1016\/j.ejca.2015.09.011","journal-title":"European Journal Cancer Oxford England"},{"key":"10262_CR98","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/JTO.0b013e31826aec2b","volume":"7","author":"GV Scagliotti","year":"2012","unstructured":"Scagliotti, G. V., Hirsh, V., Siena, S., Henry, D. H., Woll, P. J., Manegold, C., et al. (2012). Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: Subgroup analysis from a randomized phase 3 study. Journal Thoracic Oncology Office Publication International Association Study Lung Cancer, 7, 1823\u20131829. https:\/\/doi.org\/10.1097\/JTO.0b013e31826aec2b","journal-title":"Journal Thoracic Oncology Office Publication International Association Study Lung Cancer"},{"key":"10262_CR99","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.3747\/co.20.1055","volume":"20","author":"A Avil\u00e9s","year":"2013","unstructured":"Avil\u00e9s, A., Neri, N., Huerta-Guzm\u00e1n, J., & Nambo, M. J. (2013). Randomized clinical trial of zoledronic acid in multiple myeloma patients undergoing high-dose chemotherapy and stem-cell transplantation. Current Oncology Tor Ont, 20, e13-20. https:\/\/doi.org\/10.3747\/co.20.1055","journal-title":"Current Oncology Tor Ont"},{"key":"10262_CR100","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.critrevonc.2017.09.008","volume":"120","author":"S Rizzo","year":"2017","unstructured":"Rizzo, S., Galvano, A., Pantano, F., Iuliani, M., Vincenzi, B., Passiglia, F., et al. (2017). The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials. Critical Reviews in Oncology Hematology, 120, 227\u2013233. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.09.008","journal-title":"Critical Reviews in Oncology Hematology"},{"key":"10262_CR101","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1200\/JCO.2017.74.7352","volume":"36","author":"B Escudier","year":"2018","unstructured":"Escudier, B., Powles, T., Motzer, R. J., Olencki, T., Ar\u00e9n Frontera, O., Oudard, S., et al. (2018). Cabozantinib, a new standard of care for patients with advanced renal cell carcinoma and bone metastases? Subgroup Analysis of the METEOR Trial. Journal Clinical Oncology Office Journal American Society Clinical Oncology, 36, 765\u2013772. https:\/\/doi.org\/10.1200\/JCO.2017.74.7352","journal-title":"Journal Clinical Oncology Office Journal American Society Clinical Oncology"},{"key":"10262_CR102","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1200\/JCO.2015.65.5597","volume":"34","author":"M Smith","year":"2016","unstructured":"Smith, M., De Bono, J., Sternberg, C., Le Moulec, S., Oudard, S., De Giorgi, U., et al. (2016). Phase III study of cabozantinib in previously treated metastatic castration-resistant prostate cancer: COMET-1. Journal of Clinical Oncology, 34, 3005\u20133013. https:\/\/doi.org\/10.1200\/JCO.2015.65.5597","journal-title":"Journal of Clinical Oncology"},{"key":"10262_CR103","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ctrv.2012.02.008","volume":"38","author":"P Hadji","year":"2012","unstructured":"Hadji, P., Gnant, M., Body, J. J., Bundred, N. J., Brufsky, A., Coleman, R. E., et al. (2012). Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention? Cancer Treatment Reviews, 38, 798\u2013806. https:\/\/doi.org\/10.1016\/j.ctrv.2012.02.008","journal-title":"Cancer Treatment Reviews"},{"key":"10262_CR104","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/jbmr.2415","volume":"30","author":"JM Quach","year":"2015","unstructured":"Quach, J. M., Askmyr, M., Jovic, T., Baker, E. K., Walsh, N. C., Harrison, S. J., et al. (2015). Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss. Journal of Bone and Mineral Research, 30, 886\u2013897. https:\/\/doi.org\/10.1002\/jbmr.2415","journal-title":"Journal of Bone and Mineral Research"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10262-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-025-10262-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10262-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:19:28Z","timestamp":1751001568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-025-10262-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":104,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["10262"],"URL":"https:\/\/doi.org\/10.1007\/s10555-025-10262-6","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"13 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Competing Interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"45"}}